Showing results (1091-1100 of 2,595) with videos related to

Sort By:
Pageof 260
The Australasian Journal of Dermatology|January 31, 2009
Epidermodysplasia verruciformis-like syndrome in association with systemic lupus erythematosusCara Holmes, Alvin H Chong, Sepehr N Tabrizi, et al.
The Australasian Journal of Dermatology|November 3, 2022
Vitiligo and systemic sclerosis: Are they associated?- Lessons from a population-based studyKhalaf Kridin, Keren Lyakhovitsky, Dana Tzur-Bitan, et al.
The Australasian Journal of Dermatology|September 20, 2022
Utility of optical coherence tomography in basal cell naevus syndrome: A case reportGenevieve Ho, Rodrigo J Schwartz, Bruna Melhoranse-Gouveia, et al.
The Australasian Journal of Dermatology|February 29, 2024
Adult genital psoriasis: An updated review for cliniciansMichelle Wu, Gayle Fischer
The Australasian Journal of Dermatology|December 9, 2023
Calcinosis universalis accompanied by symptomatic systemic sclerosisShiling Geng, Yihua Zhang, Ting Gong, et al.
The Australasian Journal of Dermatology|November 6, 2023
Treatment of locally advanced and metastatic basosquamous carcinoma, navigating among sonic hedgehog pathway inhibitors, immune checkpoint inhibitors, chemotherapy, and radiotherapy: A case series and literature reviewEnrico Zelin, Vanessa Mazzoletti, Francesco Cavallo, et al.
The Australasian Journal of Dermatology|November 6, 2023
Combination oral antifungal therapy for paediatric fungal infection: An option to improve efficacy and overcome clinical resistanceNisal Punchihewa, David Orchard
The Australasian Journal of Dermatology|July 14, 2024
Childhood eczema prevalence in New Zealand using topical corticosteroid dispensing dataGeorgina Harvey, Diana J Purvis, John M D Thompson, et al.
The Australasian Journal of Dermatology|July 20, 2024
Successful treatment of infantile refractory bullous pemphigoid with baricitinibWeinan Zhou, Yidong Tan, Xuanyi Chen, et al.
The Australasian Journal of Dermatology|July 1, 2024
Evaluation of serial QuantiFERON-TB Gold in tube test results and tuberculosis infection status in patients with psoriasis receiving anti-IL-17 treatment (secukinumab and ixekizumab): Real-world data from a tuberculosis-endemic countryEce Erbağcı, Sema Koç Yıldırım, Fatma Aslı Hapa
Pageof 260